Skip to main navigation Skip to search Skip to main content

A Phase 1/2a, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Immunogenicity and Viral Shedding of MEDI-559, A Live Attenuated Intranasal Vaccine Against RSV in Healthy 1 to <12 Month Old Children

  • Domachowske, Joseph (PI)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date07/6/09 → 07/31/12

Funding

  • MedImmune Incorporated: $47,706.00